Literature DB >> 28943943

Curative resectability of gastrointestinal cancer identified from iron deficiency anemia.

Kenta Kawasaki1,2, Yasuo Hamamoto3, Masayasu Horibe2, Kenji Shimura1, Akira Nakamura1, Takanori Kanai2, Hiromasa Takaishi3.   

Abstract

The present study aimed to clarify the staging and curative resectability of gastrointestinal cancer found through iron deficiency anemia (IDA). An electronic database was used and females >51 and males >18 years old were identified who had been diagnosed with IDA at the internal medicine outpatient clinic of Asahi General Hospital (Chiba, Japan) from 1 April 2010 to 31 March 2012. IDA was defined as a hemoglobin level of <135 g/l for males and <120 g/l for females, combined with a serum ferritin level of <33.71 pmol/l. Of the 472 patients who had been diagnosed with IDA, 347 patients underwent either a gastroscopy and/or colonoscopy, including 120 patients who had undergone both gastroscopy and colonoscopy, 197 patients who only underwent gastroscopy, and 30 patients who only underwent colonoscopy. In total, 125/472 patients diagnosed with IDA did not undergo a gastroscopy or a colonoscopy. From the 50 patients who were diagnosed with cancer as a result of the investigation, 24 patients had gastric cancer and 23 patients had colorectal cancer. Of the gastric cancer patients, 6 patients were stage I, 3 patients stage II, 5 patients were stage III and 9 patients were stage IV. In colorectal cancer, 9 patients were stage II, 8 patients were stage III and 4 patients were stage IV. Curative surgery including endoscopic treatment was performed on 14 gastric cancer patients and 17 colorectal cancer patients of stage III or lower. Malignancies were found in 50 patients with IDA, and curative surgery was performed on >50% of the patients.

Entities:  

Keywords:  colorectal cancer; gastric cancer; gastrointestinal malignancy; iron deficiency anemia; resectability

Year:  2017        PMID: 28943943      PMCID: PMC5592875          DOI: 10.3892/ol.2017.6650

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  Evaluation of iron deficiency anaemia in tertiary hospital settings: room for improvement?

Authors:  G Khadem; I A Scott; K Klein
Journal:  Intern Med J       Date:  2012-06       Impact factor: 2.048

2.  Preoperative staging of colorectal cancer using virtual colonoscopy: correlation with surgical results.

Authors:  A Stagnitti; F Barchetti; G Barchetti; E Pasqualitto; A Sartori; M Glorioso; S Gigli; V Buonocore; M L Monti; A Marini; C Mele; F Stagnitti; A Laghi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

3.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Al B Benson; Alan P Venook; Lynette Cederquist; Emily Chan; Yi-Jen Chen; Harry S Cooper; Dustin Deming; Paul F Engstrom; Peter C Enzinger; Alessandro Fichera; Jean L Grem; Axel Grothey; Howard S Hochster; Sarah Hoffe; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Mary F Mulcahy; James D Murphy; Steven Nurkin; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Christina S Wu; Kristina M Gregory; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2017-03       Impact factor: 11.908

4.  Anaemia investigation in practice: inappropriate, cost inefficient with a risk of missing gastrointestinal cancer. Can we improve?

Authors:  Sheena Mankodi; Bu Hussain Hayee; John O'Donohue; David Reffitt
Journal:  Clin Med (Lond)       Date:  2010-04       Impact factor: 2.659

5.  A perspective on iron deficiency anaemia.

Authors:  J M Sayer; R G Long
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

6.  Predictive risk factors and prevalence of malignancy in patients with iron deficiency anemia in Taiwan.

Authors:  Chao-Hung Ho; Wing-Keung Chau; Hui-Chi Hsu; Jyh-Pyng Gau; Jie-Yu You; Chih-Cheng Chen
Journal:  Am J Hematol       Date:  2005-02       Impact factor: 10.047

7.  Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jaffer A Ajani; Thomas A D'Amico; Khaldoun Almhanna; David J Bentrem; Joseph Chao; Prajnan Das; Crystal S Denlinger; Paul Fanta; Farhood Farjah; Charles S Fuchs; Hans Gerdes; Michael Gibson; Robert E Glasgow; James A Hayman; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Dawn Jaroszewski; Kimberly L Johung; Rajesh N Keswani; Lawrence R Kleinberg; W Michael Korn; Stephen Leong; Catherine Linn; A Craig Lockhart; Quan P Ly; Mary F Mulcahy; Mark B Orringer; Kyle A Perry; George A Poultsides; Walter J Scott; Vivian E Strong; Mary Kay Washington; Benny Weksler; Christopher G Willett; Cameron D Wright; Debra Zelman; Nicole McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2016-10       Impact factor: 11.908

8.  Missed opportunities in early diagnosis of symptomatic colorectal cancer.

Authors:  Maite Domínguez-Ayala; Jonathan Díez-Vallejo; Angel Comas-Fuentes
Journal:  Rev Esp Enferm Dig       Date:  2012-07       Impact factor: 2.086

9.  [Differential factors of tumor etiology for iron deficiency anemia of probable gastrointestinal origin].

Authors:  J J Napal; J L Hernández; J Alonso; E Casuso
Journal:  Rev Clin Esp       Date:  2009-06       Impact factor: 1.556

10.  Investigation and management of iron deficiency anaemia in general practice: a cluster randomised controlled trial of a simple management prompt.

Authors:  E C M Logan; J M Yates; R M Stewart; K Fielding; D Kendrick
Journal:  Postgrad Med J       Date:  2002-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.